Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiqi Fumai Injection plus GDMT for exercise tolerance in chronic heart failure
ChiCTR2400079378Phase 4Not yet recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jan 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of yiqi fumai in chronic heart failure (CHF) (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Veterans Specific Activity Questionnaire (VSAQ). Planned start Jan 2024; status: not yet recruiting.
02
Drugs
yiqi fumai
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR2400079378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079378.